Cigna Co. (NYSE:CI) CEO David Cordani Sells 45,380 Shares

Cigna Co. (NYSE:CIGet Rating) CEO David Cordani sold 45,380 shares of the firm’s stock in a transaction dated Wednesday, April 20th. The stock was sold at an average price of $268.10, for a total value of $12,166,378.00. Following the completion of the transaction, the chief executive officer now owns 152,750 shares of the company’s stock, valued at $40,952,275. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

David Cordani also recently made the following trade(s):

  • On Monday, April 18th, David Cordani sold 3,717 shares of Cigna stock. The shares were sold at an average price of $260.89, for a total value of $969,728.13.
  • On Monday, February 28th, David Cordani sold 10,069 shares of Cigna stock. The shares were sold at an average price of $228.70, for a total value of $2,302,780.30.

NYSE CI traded down $9.55 on Friday, reaching $255.06. 1,249,449 shares of the company were exchanged, compared to its average volume of 1,666,311. The business’s fifty day moving average price is $241.35 and its 200 day moving average price is $227.08. The stock has a market capitalization of $81.21 billion, a P/E ratio of 16.20, a price-to-earnings-growth ratio of 1.04 and a beta of 0.86. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.66. Cigna Co. has a fifty-two week low of $191.74 and a fifty-two week high of $272.81.

Cigna (NYSE:CIGet Rating) last posted its earnings results on Thursday, February 3rd. The health services provider reported $4.77 EPS for the quarter, beating the Zacks’ consensus estimate of $4.68 by $0.09. Cigna had a return on equity of 14.59% and a net margin of 3.08%. The company had revenue of $45.69 billion for the quarter, compared to the consensus estimate of $43.98 billion. During the same quarter in the previous year, the business earned $3.51 earnings per share. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. Equities research analysts forecast that Cigna Co. will post 22.5 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 24th. Shareholders of record on Wednesday, March 9th were given a $1.12 dividend. The ex-dividend date was Tuesday, March 8th. This represents a $4.48 dividend on an annualized basis and a yield of 1.76%. This is an increase from Cigna’s previous quarterly dividend of $1.00. Cigna’s payout ratio is currently 28.46%.

Several brokerages have commented on CI. Stephens raised their price objective on Cigna from $265.00 to $290.00 and gave the company an “overweight” rating in a report on Wednesday. Truist Financial raised their price objective on Cigna from $275.00 to $290.00 in a report on Thursday, April 7th. Zacks Investment Research raised Cigna from a “hold” rating to a “buy” rating and set a $274.00 price objective on the stock in a report on Wednesday. Deutsche Bank Aktiengesellschaft lowered Cigna from a “buy” rating to a “hold” rating and dropped their price objective for the company from $271.00 to $236.00 in a report on Friday, February 4th. Finally, Wells Fargo & Company raised Cigna from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $236.00 to $278.00 in a report on Thursday, January 6th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Cigna presently has an average rating of “Buy” and an average target price of $261.35.

A number of large investors have recently bought and sold shares of CI. Sigma Planning Corp raised its position in Cigna by 121.6% in the third quarter. Sigma Planning Corp now owns 3,116 shares of the health services provider’s stock valued at $624,000 after purchasing an additional 1,710 shares during the period. Vontobel Holding Ltd. raised its position in Cigna by 26.6% in the third quarter. Vontobel Holding Ltd. now owns 8,508 shares of the health services provider’s stock valued at $1,703,000 after purchasing an additional 1,790 shares during the period. GWM Advisors LLC raised its holdings in shares of Cigna by 587.8% in the 3rd quarter. GWM Advisors LLC now owns 6,053 shares of the health services provider’s stock valued at $1,212,000 after buying an additional 5,173 shares during the period. Miracle Mile Advisors LLC purchased a new stake in shares of Cigna in the 3rd quarter valued at $357,000. Finally, Independent Advisor Alliance raised its holdings in shares of Cigna by 12.1% in the 3rd quarter. Independent Advisor Alliance now owns 1,268 shares of the health services provider’s stock valued at $254,000 after buying an additional 137 shares during the period. Institutional investors own 86.39% of the company’s stock.

Cigna Company Profile (Get Rating)

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers.

Read More

Insider Buying and Selling by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.